Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
439.11
389.26
460.42
415.09
419.97
402.00
387.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
439.11
389.26
460.42
415.09
419.97
402.00
387.42
Raw Material Cost
202.66
191.53
212.12
166.41
177.84
165.66
166.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.78
9.16
9.20
8.84
8.51
8.15
9.60
Selling and Distribution Expenses
69.90
73.42
69.93
69.07
75.29
68.75
85.72
Other Expenses
2.58
2.39
2.55
2.75
2.72
1.99
2.70
Total Expenditure (Excl Depreciation)
307.09
297.97
316.72
271.84
288.80
262.45
288.43
Operating Profit (PBDIT) excl Other Income
132
91.30000000000001
143.7
143.2
131.2
139.5
99
Other Income
-9.66
-4.79
-2.02
2.77
7.22
11.35
15.16
Operating Profit (PBDIT)
162.83
128.93
160.66
181.11
160.46
174.63
113.71
Interest
8.78
9.16
9.20
8.84
8.51
8.15
9.60
Exceptional Items
-1.43
2.60
0.38
1.86
0.61
1.59
1.59
Gross Profit (PBDT)
236.45
197.73
248.31
248.68
242.13
236.34
221.29
Depreciation
45.23
45.23
37.61
37.61
26.54
26.54
22.89
Profit Before Tax
107.40
77.14
114.22
136.52
126.02
141.54
82.81
Tax
12.58
13.21
18.55
17.87
10.54
22.12
11.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
94.82
63.93
95.67
118.64
115.48
119.42
71.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
94.82
63.93
95.67
118.64
115.48
119.42
71.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
94.82
63.93
95.67
118.64
115.48
119.42
71.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,675.86
2,718.40
2,657.56
2,541.18
2,429.25
2,440.58
2,331.53
Earnings per share (EPS)
0.23
0.16
0.22
0.29
0.29
0.3
0.18
Diluted Earnings per share
0.23
0.16
0.22
0.29
0.29
0.3
0.18
Operating Profit Margin (Excl OI)
28.98%
22.73%
27.16%
33.9%
30.17%
34.02%
19.53%
Gross Profit Margin
34.76%
31.44%
32.98%
41.95%
36.33%
41.81%
27.28%
PAT Margin
21.59%
16.42%
20.78%
28.58%
27.5%
29.71%
18.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 4.55% vs 6.33% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -17.92% vs 8.55% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 12.60% vs 17.39% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 3.53% vs 2,025.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Aurisco Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
439.11
0
439.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
439.11
0
439.11
Raw Material Cost
202.66
0
202.66
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.78
0
8.78
Selling and Distribution Expenses
69.90
0
69.90
Other Expenses
2.58
0.00
2.58
Total Expenditure (Excl Depreciation)
307.09
0
307.09
Operating Profit (PBDIT) excl Other Income
132.02
0.00
132.02
Other Income
-9.66
0
-9.66
Operating Profit (PBDIT)
162.83
0
162.83
Interest
8.78
0
8.78
Exceptional Items
-1.43
0
-1.43
Gross Profit (PBDT)
236.45
0
236.45
Depreciation
45.23
0
45.23
Profit Before Tax
107.40
0
107.40
Tax
12.58
0
12.58
Provisions and contingencies
0
0
0.00
Profit After Tax
94.82
0
94.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
94.82
0
94.82
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
94.82
0
94.82
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,675.86
0
2,675.86
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
28.98%
0%
0.00
28.98%
Gross Profit Margin
34.76%
0%
0.00
34.76%
PAT Margin
21.59%
0%
0.00
21.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.91 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 12.79% vs -15.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 4.55% vs 6.33% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.48 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 48.36% vs -33.23% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -17.92% vs 8.55% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.25 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 29.02% vs -17.82% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 12.60% vs 17.39% in Jun 2025
Quarterly - Interest
Interest 0.88 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -4.35% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3.53% vs 2,025.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.98%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
